Example: Heart Attack

Search clinical trials for: Advanced NET of GI origin

Total 10000 results

NCT01524783

Completed

Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) (RADIANT-4)

Neuroendocrine Tumors | Advanced NET of GI Origin | Advanced NET of Lung Origin
NCT02955069

Completed

Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)

Well-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma
NCT06855225

Not yet recruiting

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

Combined Hepatocellular and Cholangiocarcinoma
NCT06835387

Recruiting

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Small Bowel Adenocarcinoma
NCT06728410

Recruiting

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Gene Rearrangement

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register